Skip to main content

Table 4 Measurement of dyspnoea, COPD specific health status, quality of life, exercise capacity and physical activity

From: Consequences of chronic kidney disease in chronic obstructive pulmonary disease

 

N

All

No CKD

CKD

p value

mMRC

2260

   

< 0.0001

0

 

207 (9.2)

196 (9.3)

12 (7.5)

 

1

 

1067 (47.2)

1014 (48.3)

53 (32.9)

 

2

 

614 (27.2)

557 (26.5)

57 (35.4)

 

3

 

353 (15.6)

317 (15.1)

36 (22.4)

 

4

 

19 (0.9)

16 (0.8)

3 (1.9)

 

CAT

2263

17.8 ± 7.2

17.8 ± 7.2

17.4 ± 7.0

0.5117

SGRQ

2259

41.7 ± 19.6

41.5 ± 19.5

44.0 ± 19.9

0.1196

EQ 5D

2266

0.8 ± 0.2

0.8 ± 0.2

0.8 ± 0.2

0.6427

6MWD

2225

424.7 ± 105.2

427.6 ± 104.3

385.9 ± 110.1

< 0.0001

TuG (sec.)

2224

6.9 ± 2.2

6.9 ± 2.2

7.5 ± 2.4

0.0004

  1. Abbreviations: mMRC Modified British Medical Research Council dyspnoea scale, CAT COPD Assessment Test, 6-MWD Six minute walk distance, SGRQ St George’s Respiratory Questionnaire, EQ-5D EuroQol- 5 dimension. Values are presented as N (%) or mean ± SD. p ≤ 0.05 was considered statistically significant (bold)